Hadron Energy (HDRN) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
5 Oct, 2026Company overview and business model
Newly formed Cayman Islands SPAC seeking a merger, acquisition or similar business combination; no target selected as of the filing date.
Global target search, with intended focus on TMT, AI/ML, cybersecurity, MedTech, semiconductors and sustainable industries; strategy emphasizes established, mid-sized businesses with differentiated offerings and strong management.
Post-combination plan: support operating strategy, improve organic growth and global operations, and pursue add-on acquisitions to build industry platforms.
Financial performance and metrics
For May 8–31, 2024, reported $17,652 net loss, no revenue, $100,000 cash and $82,348 working capital.
Auditor cited substantial doubt about ability to continue as a going concern; activity to date was limited to formation and IPO preparation.
Pro forma dilution for investors not redeeming: $10.14 per share, or 101.4%, without over-allotment; filing’s illustrative combination scenario implies $6.00 per share.
Use of proceeds and capital allocation
IPO proceeds and concurrent placements are expected to put $250 million in trust, or $287.5 million with full over-allotment; trust assets restricted to short-term U.S. government securities or qualifying money market funds.
Estimated $2.05 million outside trust is allocated to deal diligence and legal costs, reporting, office and administrative fees, D&O insurance, CFO payments and working capital for up to 21 months.
Trust funds may fund a transaction, redemption payments and related expenses; unused cash after a combination may support operations, debt service, acquisitions or working capital.
Latest events from Hadron Energy
- Higher costs cut Q1 net income; merger closing hinges on cash, approvals and redemptions.HDRN
Q1 2026 - A $250 million SPAC raise pairs a 24-month acquisition search with substantial dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest drove SPAC income as the microreactor target remained loss-making and pre-commercial.HDRN
Q4 2025 - Trust interest lifted Q1 profit as target search and going-concern risks persist.HDRN
Q1 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - Trust income drove earnings, but no target and limited operating cash sustain execution risk.HDRN
Q2 2025 - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing